These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1940587)

  • 1. Treatment of Wilson's disease with zinc. IX: Response of serum lipids.
    Brewer GJ; Yuzbasiyan-Gurkan V; Johnson V
    J Lab Clin Med; 1991 Nov; 118(5):466-70. PubMed ID: 1940587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis.
    Brewer GJ; Dick RD; Yuzbasiyan-Gurkan V; Johnson V; Wang Y
    J Lab Clin Med; 1994 Jun; 123(6):849-58. PubMed ID: 8201263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Wilson's disease with zinc: III. Prevention of reaccumulation of hepatic copper.
    Brewer GJ; Hill GM; Dick RD; Nostrant TT; Sams JS; Wells JJ; Prasad AS
    J Lab Clin Med; 1987 May; 109(5):526-31. PubMed ID: 3572199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
    Hoogenraad TU
    Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Wilson's disease with zinc. V. Changes in serum levels of lipase, amylase, and alkaline phosphatase in patients with Wilson's disease.
    Yuzbasiyan-Gurkan V; Brewer GJ; Abrams GD; Main B; Giacherio D
    J Lab Clin Med; 1989 Nov; 114(5):520-6. PubMed ID: 2478644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
    Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc therapy in Wilson's disease: observations in five patients.
    Rossaro L; Sturniolo GC; Giacon G; Montino MC; Lecis PE; Schade RR; Corazza GR; Trevisan C; Naccarato R
    Am J Gastroenterol; 1990 Jun; 85(6):665-8. PubMed ID: 2353684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
    Ramadori G; Keidl E; Hütteroth T; Dormeyer HH; Manns M; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1985 Jan; 23(1):25-9. PubMed ID: 4060799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of Wilson's disease with zinc. 5 cases].
    Bona I; Broussolle E; Neuschwander P; Confavreux C; Fontanges T; Accominotti M; Chazot G
    Rev Neurol (Paris); 1993; 149(6-7):393-7. PubMed ID: 8303158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of Kayser-Fleischer rings during oral zinc therapy: correlation with systemic manifestations of Wilson's disease.
    Esmaeli B; Burnstine MA; Martonyi CL; Sugar A; Johnson V; Brewer GJ
    Cornea; 1996 Nov; 15(6):582-8. PubMed ID: 8899270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
    Farinati F; Cardin R; D'inca R; Naccarato R; Sturniolo GC
    J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Wilson's disease with zinc. VI. Initial treatment studies.
    Brewer GJ; Yuzbasiyan-Gurkan V; Lee DY; Appelman H
    J Lab Clin Med; 1989 Dec; 114(6):633-8. PubMed ID: 2592853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Wilson's disease with zinc XVI: treatment during the pediatric years.
    Brewer GJ; Dick RD; Johnson VD; Fink JK; Kluin KJ; Daniels S
    J Lab Clin Med; 2001 Mar; 137(3):191-8. PubMed ID: 11241029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc and tetrathiomolybdate for the treatment of Wilson's disease and the potential efficacy of anticopper therapy in a wide variety of diseases.
    Brewer GJ
    Metallomics; 2009; 1(3):199-206. PubMed ID: 21305118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Wilson's disease with zinc: X. Intestinal metallothionein induction.
    Yuzbasiyan-Gurkan V; Grider A; Nostrant T; Cousins RJ; Brewer GJ
    J Lab Clin Med; 1992 Sep; 120(3):380-6. PubMed ID: 1517684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Maintenance treatment of Wilson's disease with oral zinc. Apropos of a child treated for 4 years].
    Alexiou D; Hatzis T; Koutselinis A
    Arch Fr Pediatr; 1985; 42(6):447-9. PubMed ID: 4051676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Copper in the feces--a marker for the effectiveness of zinc in the treatment of Wilson's disease].
    Dastych M
    Z Gastroenterol; 1990 Aug; 28(8):389-91. PubMed ID: 2275259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy.
    Brewer GJ; Johnson VD; Dick RD; Hedera P; Fink JK; Kluin KJ
    Hepatology; 2000 Feb; 31(2):364-70. PubMed ID: 10655259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc.
    Askari FK; Greenson J; Dick RD; Johnson VD; Brewer GJ
    J Lab Clin Med; 2003 Dec; 142(6):385-90. PubMed ID: 14713890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.